Categorías
- Instrumentos
- Agitadores / Agit. Incubadores
- Orbitales
- Con Incubación
- Incubadores Gran Capacidad
- Lineales, Balanceo y 3D
- Incubadores Microplacas
- Para colocar en estufa
- Magnéticos
- Mezcladores /Roller /Rotatorios
- Agitadores de Paletas
- Jeio Tech Accesorios para Agitadores
- Benchmark Accesorios para Agitadores
- N-Biotek Accesorios para Agitadores
- Biosan Accesorios para Agitadores
- Labnet Int. Accesorios para Agitadores
- Vórtex
- Analisis Imagen, animales, plantas, geles
- Balanzas
- Baños Termostáticos
- Cabinas Flujo / Extraccion gases / PCR
- Centrifugas
- Detectores de Radioactividad
- Electroforesis
- Electroquímica
- Equipos Microplacas
- Espectrofotometros
- Experimentacion Animal
- Hornos de Hibridacion
- Homogeneizadores
- Estufas / Equipos calor, frio
- Luminómetros de Tubos
- Microbiologia
- Pipetas / Dispensadores
- Pipetas Labnet Int. Monocanales Automaticos
- Pipetas HTL Monocanales Automáticas
- Pipeta Accumax Mono y Multicanales
- Pipetas Labnet Int. Multicanales
- Pipetas HTL Multicanales
- Pipetas Volumen Fijo
- Pipetas Electrónicas
- Dispensadores
- Dispensadores de Botella
- Pipetas Biosan Monocanales
- Pipetas Biosan Multicanales
- PCR / Tiempo Real (qPCR)l / Cicladores
- QPCR, Sistemas automaticos
- Sonicadores / Ultrasonidos
- Ultracongeladores
- Bombas Jeringa / Vacio / Osmoticas
- Ultracentrífugas
- Micro Array label free
- Contadores de Células
- Contenedores Criogenicos
- Producción agua ultrapura
- Electrospinning
- Agitadores / Agit. Incubadores
- Reactivos
- Consumibles
- Catálogos PDF
Listado de productos por fabricante AbMole
ZK53
ZK53 is a selective activator of mitochondrial caseinolytic protease P (HsClpP), with EC50 of 1.37 μM for α-casein hydrolysis by HsClpP. ZK53 induces apoptosis in H1703, H520 and SK-MES-1 cells.
ZK53
ZK53 is a selective activator of mitochondrial caseinolytic protease P (HsClpP), with EC50 of 1.37 μM for α-casein hydrolysis by HsClpP. ZK53 induces apoptosis in H1703, H520 and SK-MES-1 cells.
ZK53
ZK53 is a selective activator of mitochondrial caseinolytic protease P (HsClpP), with EC50 of 1.37 μM for α-casein hydrolysis by HsClpP. ZK53 induces apoptosis in H1703, H520 and SK-MES-1 cells.
ZK53
ZK53 is a selective activator of mitochondrial caseinolytic protease P (HsClpP), with EC50 of 1.37 μM for α-casein hydrolysis by HsClpP. ZK53 induces apoptosis in H1703, H520 and SK-MES-1 cells.
ZL006
ZL006 inhibits the ischemia-induced interaction of nNOS with postsynaptic density protein-95 (PSD-95), preventing glutamate-induced excitotoxicity and cerebral ischemic damage.
ZL006
ZL006 inhibits the ischemia-induced interaction of nNOS with postsynaptic density protein-95 (PSD-95), preventing glutamate-induced excitotoxicity and cerebral ischemic damage.
ZL006
ZL006 inhibits the ischemia-induced interaction of nNOS with postsynaptic density protein-95 (PSD-95), preventing glutamate-induced excitotoxicity and cerebral ischemic damage.
ZL0580
ZL0580 is a structural analogue of ZL0590 that induces epigenetic suppression of HIV by selectively binding to the BRD4 domain of BD1. ZL0580 induces inhibition of HIV by inhibiting Tat transcriptional activation and transcriptional prolongation, as well as inducing inhibition of chromatin structures on an HIV promoter.
ZL0580
ZL0580 is a structural analogue of ZL0590 that induces epigenetic suppression of HIV by selectively binding to the BRD4 domain of BD1. ZL0580 induces inhibition of HIV by inhibiting Tat transcriptional activation and transcriptional prolongation, as well as inducing inhibition of chromatin structures on an HIV promoter.
ZL0580
ZL0580 is a structural analogue of ZL0590 that induces epigenetic suppression of HIV by selectively binding to the BRD4 domain of BD1. ZL0580 induces inhibition of HIV by inhibiting Tat transcriptional activation and transcriptional prolongation, as well as inducing inhibition of chromatin structures on an HIV promoter.
ZL0590
ZL0590 is a potent, orally active BRD4 BD1-selective inhibitor with an IC50 of 90 nM for human BRD4 BD1. ZL0590 exhibits significant anti-inflammatory activities.
ZL0590
ZL0590 is a potent, orally active BRD4 BD1-selective inhibitor with an IC50 of 90 nM for human BRD4 BD1. ZL0590 exhibits significant anti-inflammatory activities.